VISION

Inspiring transformational change in the

field of oncology diagnostics

MISSION

To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies


Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.

Latest News

@ArquerDx

- 7 hours ago

#SIU2017 comes to a close today. It's been a pleasure to be here, and thank you to everyone involved in the launch… https://t.co/FahMbx5mS9
@ArquerDx

- 11 hours ago

RT @alphalabs: Missed @ArquerDx SIU@U Studio Session yesterday? Still available on-demand on SIU@U #bladder #cancer #Diagnostics Visit it…
@ArquerDx

- 1 day ago

Here’s a #selfie of our CEO, Nadia Whittley, at a studio session on #ADXBLADDER - it’s almost time to launch!… https://t.co/rOy8omh5iF